CXCR2 and neoplasm: Alyssa D. Gregory and A. Mc Garry Houghton suggest two different possible strategies: (a) targeting the “CXCL-8/CXCR-1/CXCR-2 axis,” thereby entirely exhausting TANs or (b) targeting specific PMN-derived substances able to induce tumor growing (13).